Fundraising FoxEmerging Therapy Solutions
Bloomington, US · Founded 2018 · Delaware corporation · 1 known investors
Find your way into Emerging Therapy Solutions
Sign up to see every warm intro you have to Emerging Therapy Solutions
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Emerging Therapy Solutions team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
SL
Steve LefarNamed on SEC filing
DM
David McLeanNamed on SEC filing
RN
Ravi NalliahNamed on SEC filing
KR
Kevin RocheNamed on SEC filing
Board
JW
JM
Investors · 1
Telegraph Hill PartnersreportedSan Francisco · $2M – $8Mvia Rob Capone · board
How we know: board seat on SEC Form D · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$24.3M disclosed across 7 rounds · 2018–2024
▶$5MraisedMar 2024 · 5 investors · Other Health CareRule 506(b)
▶$5MraisedMar 2024 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ravi NalliahDirector
- J. Matthew MackowskiDirector
- Nathan SchmidtExecutive Officer
- Larry KocotDirector
- Kevin RocheExecutive Officer, Director
- Mike BurkeDirector
- Gary CurtisDirector
- Rob CaponeDirector
- Ashley HumeExecutive Officer
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedDec 2022 · 5 investors · Other Health CareRule 506(b)
▶$3MraisedDec 2022 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Gary CurtisDirector
- David McLeanExecutive Officer, Director
- Ravi NaliahDirector
- Mike BurkeDirector
- Rob CaponeDirector
- J. Matthew MackowskiDirector
- Kevin RocheExecutive Officer, Director
- Amount sold
- $3M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$6MraisedJun 2021 · 5 investors · Other Health CareRule 506(b)
▶$6MraisedJun 2021 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeanette WelshDirector
- Steve LefarDirector
- David McLeanExecutive Officer, Director
- Ravi NalliahDirector
- J. Matthew MackowskiDirector
- Kevin RocheExecutive Officer, Director
- Amount sold
- $6M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$1MraisedFeb 2021 · 5 investors · Other Health CareRule 506(b)
▶$1MraisedFeb 2021 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ravi NalliahDirector
- Jeanette WelshDirector
- J. Matthew MackowskiDirector
- David McLeanExecutive Officer, Director
- Kevin RocheExecutive Officer, Director
- Steve LefarDirector
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$3MraisedFeb 2020 · 5 investors · Other Health CareRule 506(b)
▶$3MraisedFeb 2020 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeanette WelshDirector
- Steve LefarDirector
- Ravi NalliahDirector
- J. Matthew MackowskiDirector
- Kevin RocheExecutive Officer, Director
- David McLeanExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$1MraisedMay 2019 · 1 investors · Other Health CareRule 506(b)
▶$1MraisedMay 2019 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeanette WelshDirector
- Ravi NalliahDirector
- Matt MackowskiDirector
- Kevin RocheExecutive Officer, Director
- David McLeanExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$5.3MraisedJan 2019 · 4 investors · Other Health CareRule 506(b)
▶$5.3MraisedJan 2019 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeanette WelshDirector
- David McLeanExecutive Officer, Director
- Matt MackowskiDirector
- Kevin RocheExecutive Officer, Director
- Amount sold
- $5.3M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Emerging Therapy Solutions's investors?
- Emerging Therapy Solutions's investors include Telegraph Hill Partners.
- How much funding has Emerging Therapy Solutions raised?
- Emerging Therapy Solutions has disclosed $24.3M raised across 7 rounds.
- Where is Emerging Therapy Solutions headquartered?
- Emerging Therapy Solutions is headquartered in Bloomington, US.